Financial Times
US Regulators Take Aim at Serena Williams-backed Venture While Novartis Warns of Price Hike for Cancer Drug
Regulators target Serena Williams-backed company as Novartis reveals plans to keep prostate cancer drug prices high. Find out more!
See more